TORNTPHARMNSETorrent Pharmaceuticals Limited· PharmaceuticalsMediumNeutral
Announced Fri, 5 Jun · 11:54 IST

Torrent Investments Limited (formerly known as Torrent Investments Private Limited) has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Ownership Changes View source PDF

TORNTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.8%1-day move
₹4330.10
prior close
₹4406.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2+0.4+0.3+0.8+1.8+3.1+2.9+6.0+5.7+3.2+7.3+11.4
Up moveDown movePending
AI summary

Torrent Investments Limited, the promoter holding company of Torrent Pharmaceuticals, has filed a disclosure with the exchange under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation requires promoters and persons acting in concert to disclose any creation, invocation, or release of encumbrance (pledge) on their shares. The filing confirms a pledge-related event involving the promoter's stake, though the specific details such as whether the pledge was created, invoked, or released are not mentioned in the headline. Shareholders should look to the full disclosure document on the NSE/BSE website for exact figures and the nature of the encumbrance change.

Likely market impact

This is a routine regulatory disclosure related to promoter share encumbrance activity. The actual impact on shareholders depends on whether the pledge was newly created, released, or invoked — release is generally positive, while new pledges or invocations may raise concerns about promoter leverage. Watch for the detailed disclosure to gauge sentiment.